https://orcid.org/0000-0003-3436-2651
References
- Choe C, Bacal DA, O’Brien JM, et al. Retinoblastoma. AAO EyeWiki; June 4, 2020. Available from: https://eyewiki.aao.org/Retinoblastoma.
- Broaddus E, Topham A, Singh AD. Incidence of retinoblastoma in the USA: 1975–2004. Br J Ophthalmol. 2008;93(1):21–23. doi:10.1136/bjo.2008.138750
- Jenkinson H. Retinoblastoma: diagnosis and management—the UK perspective. Arch Dis Child. 2015;100(11):1070–1075. doi:10.1136/archdischild-2014-306208
- Park SJ, Woo SJ, Park KH. Incidence of retinoblastoma and survival rate of retinoblastoma patients in Korea using the Korean national cancer registry database (1993–2010). Invest Ophthalmol Vis Sci. 2014;55(5):2816–2821. doi:10.1167/iovs.14-14078
- Marees T, van Leeuwen FE, de Boer MR, Imhof SM, Ringens PJ, Moll AC. Cancer mortality in long-term survivors of retinoblastoma. Eur J Cancer. 2009;45(18):3245–3253. doi:10.1016/j.ejca.2009.05.011
- Shields CL, Fulco EM, Arias JD, et al. Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Eye. 2013;27(2):253–264. doi:10.1038/eye.2012.175
- Rodriguez-Galindo C, Wilson MW, Chantada G, et al. Retinoblastoma: one world, one vision. Pediatrics. 2008;122(3):e763–70. doi:10.1542/peds.2008-0518
- Kivelä T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93(9):1129–1131. doi:10.1136/bjo.2008.150292
- Fernandes AG, Pollock BD, Rabito FA. Retinoblastoma in the United States: a 40-year incidence and survival analysis. J Pediatr Ophthalmol Strabismus. 2018;55(3):182–188. doi:10.3928/01913913-20171116-03
- Andreoli MT, Chau FY, Shapiro MJ, Leiderman YI. Epidemiological trends in 1452 cases of retinoblastoma from the surveillance, epidemiology, and end results (SEER) registry. Can J Ophthalmol. 2017;52(6):592–598. doi:10.1016/j.jcjo.2017.05.012
- Al-Nawaiseh I, Jammal HM, Khader YS, Jaradat I, Barham R. Retinoblastoma in Jordan, 2003–2013: ocular survival and associated factors. Ophthalmic Epidemiol. 2014;21(6):406–411. doi:10.3109/09286586.2014.967781
- Surveillance, Epidemiology, and End Results (SEER) Program. SEER*stat database: incidence – SEER 18 regs custom data (with additional treatment fields), Nov 2018 Sub (1975–2016 varying)-linked to county attributes – total U.S., 1969–2016 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, based on the November 2018 submission. Available from: www.seer.cancer.gov. Accessed December 10, 2020.
- Yu CL, Tucker MA, Abramson DH, et al. Cause-specific mortality in long-term survivors of retinoblastoma. J Natl Cancer Inst. 2009;101(8):581–591. doi:10.1093/jnci/djp046
- Kleinerman RA, Tucker MA, Sigel BS, Abramson DH, Seddon JM, Morton LM. Patterns of cause-specific mortality among 2053 survivors of retinoblastoma, 1914–2016. J Natl Cancer Inst. 2019;111(9):961–969. doi:10.1093/jnci/djy227
- Brichard B, Heusterspreute M, De Potter P, et al. Unilateral retinoblastoma, lack of familial history and older age does not exclude germline RB1 gene mutation. Eur J Cancer. 2006;42(1):65–72. doi:10.1016/j.ejca.2005.07.027
- Gregersen PA, Olsen MH, Urbak SF, et al. Incidence and mortality of second primary cancers in Danish patients with retinoblastoma, 1943–2013. JAMA Netw Open. 2020;3(10):e2022126. doi:10.1001/jamanetworkopen.2020.22126